Chatsirisupachai et al. demonstrated that TP53 and CTNNB1 mutations were more common in younger CRC patients, while APC, KRAS, and BRAF V600E mutations predominated in older ones [31]. The gene discussed is KRAS; the disease is colorectal carcinoma.